ValiRx (LON:VAL) Share Price Passes Below 200-Day Moving Average of $4.01

ValiRx plc (LON:VAL) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 4.01 ($0.05) and traded as low as GBX 2.90 ($0.04). ValiRx shares last traded at GBX 3 ($0.04), with a volume of 235,989 shares.

ValiRx Price Performance

The stock’s fifty day moving average is GBX 2.93 and its 200-day moving average is GBX 4.01. The stock has a market capitalization of £3.88 million, a PE ratio of -150.00 and a beta of 0.63. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.64 and a quick ratio of 1.27.

ValiRx Company Profile

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer.